First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating ...
IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, production, and commercialization of novel cell therapies, today announced that the Blood ...
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression ...
Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q3 2025 Earnings Call October 22, 2025 4:30 PM EDT Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator ...
Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), today announced positive results from its Phase 2 study of oral, once-daily VTX3232 in patients with Obesity and Cardiovascular Risk ...
The "Global Industrial Decarbonization Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The industrial sector accounts for approximately 30% of global greenhouse gas ...
AP3 Generative AI KaiSR model globally assesses drug effects on the entire intracellular protein signaling network for optimal drug design and ...
Welcome back Behind Cosmetic Surgery by Dr Piya where your questions meet expert insights from Dr Piya Rungruxsiri, MD, board ...
Almost 3 out of 4 retired players with the painful condition had suffered "significant" foot or ankle injuries during their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback